The real-life impact of vaccination on COVID-19 mortality in Europe and Israel
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Article activity feed
-
-
SciScore for 10.1101/2021.05.26.21257844: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources Analyses were performed using SAS 9.4 software. SASsuggested: (SASqPCR, RRID:SCR_003056)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:Limitations: Our study has several limitations. Firstly, our analysis was conducted on a country-level basis to estimate the vaccination efficacy, which should be seen as less precise method compared to analysis of individual-level data, …
SciScore for 10.1101/2021.05.26.21257844: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources Analyses were performed using SAS 9.4 software. SASsuggested: (SASqPCR, RRID:SCR_003056)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:Limitations: Our study has several limitations. Firstly, our analysis was conducted on a country-level basis to estimate the vaccination efficacy, which should be seen as less precise method compared to analysis of individual-level data, as previously noted. However, given the range of included countries, our results shed light on the problem of vaccination effectiveness from a broader perspective and investigate the effect of vaccination across societies, considering variability of vaccination coverage through time and between countries. Secondly, the quality of data on variants distribution varied between countries and was low for some of them, therefore, results of the exploratory analysis should be treated with cautious. To limit bias and avoid fluctuations, we employed methods of interpolation and smoothing. Countries with limited data were excluded. Thirdly, the set of covariates used in the multivariate analysis can be assessed as non-exhaustive. We decided to consider factors which were previously assessed as significantly impacting the risk of severe illness or mortality from COVID-19 in the literature.50-53 Finally, we were not able to consider other new SARS-CoV-2 VOCs, except B.1.1.7, in the current analysis, which was due to their limited spread in Europe as of April 2021. It rises a need for further research on this topic in the future. Conclusions: This study confirms a strong effectiveness of COVID-19 vaccination based on real-life public data, in terms of pro...
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-
